DFX Intelligence

Data Factory

VentureFirminstitutional vc · probableregistered_investment_adviser

NEW Rhein Healthcare Investors LLC

Venture Capital

Philadelphia, PA

New Rhein deploys a hands-on private equity approach when working with our portfolio companies to drive positive outcomes. We combine extensive deal making expertise with deep operating experience, take a significant stake in a small number of companies and actively manage their value creation.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:8c930703-26ab-4176-ba2f-559fed009018

Data as of Sep 12, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 10:09 PM UTC and rebuilt at most every 15 minutes.

Relationships: 42
Dated events: 9
On other graphs: 2
Observed: Sep 12, 2026 to Sep 12, 2026
35 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

NEW Rhein Healthcare Investors LLC

Private equity manager · shared crd

RIA / Wealth Managementidentity

NEW RHEIN HEALTHCARE INVESTORS LLC

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 5
Vintages: 2018 to 2021
Reported GAV: $145Mgross asset value on Form ADV; never dry powder
Regulatory AUM: $291M
Funds with fundraising evidence: 0derived
Investments: 22
Portfolio companies: 22
Investments, 12m: 22
Partner-attributed: 0
People: 15
Investment professionals: 8derived
Co-investors: 0derived
LP relationships: 0
Stated sectors: healthcare,biotech,medtechas stated by the firm
Stated geography: boston,europe,france,global,india,israel,philadelphia,washington, dc
Latest Form D: Sep 20, 2022
Latest ADV filing: Mar 30, 2026
Website: newrhein.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV
NEW Rhein Healthcare 2021 (de) LP	2021	Mature	$105M	$19.0M
NEW Rhein Healthcare 2021 Privak	2021	Mature	n/a	$20.3M
NEW Rhein Healthcare 2021 (lux) Scsp	2021	Mature	$105M	$34.5M
NEW Rhein Healthcare 18 (parallel) Scsp	2020	Mature	$0	$30.1M
NEW Rhein Healthcare 18 LP	2018	Harvest	$30.1M	$40.7M

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Alveus Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
American Injectables Inc.	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Biocartis	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Butterfly Medical	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Chase Pharmaceuticals	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Corsair Pharma	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Neuraptive	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Novagali Pharma	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
SAYVAA Pharma	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Softhale	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Theranica	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Mobile digital solutions to the field of pain therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Transdermal Patch for PAH	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
U.S.-Based CDMO for Sterile Injectables with Global Impact	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Redefining Weight Management	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Soft-Mist Inhaler technology	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Oral Reformulation of Effective Antiviral	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
The future of nerve repair	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Develops an innovative, implantable device for treatment of BPH	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Dry Eye Treatment	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Alzheimers Disease Treatment	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026
Point of Care Oncology Diagnostics	n/a	n/a	n/a	n/a	Unknown	Sep 14, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
NEW Rhein Healthcare Investors LLC	Advent Life Sciences LLP	1	1	Sep 16, 2026	One time
Amoon Ventures Y.SH. Ltd.	NEW Rhein Healthcare Investors LLC	1	1	Sep 16, 2026	One time

Relationships

Invested in (22)

→ Oral Reformulation of Effective AntiviralCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ American Injectables Inc.CompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ BiocartisCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Butterfly MedicalCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Chase PharmaceuticalsCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Corsair PharmaCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ NeuraptiveCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Novagali PharmaCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ SAYVAA PharmaCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ SofthaleCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ TheranicaCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Mobile digital solutions to the field of pain therapeuticsCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Transdermal Patch for PAHCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ U.S.-Based CDMO for Sterile Injectables with Global ImpactCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Redefining Weight ManagementCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Soft-Mist Inhaler technologyCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ The future of nerve repairCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Develops an innovative, implantable device for treatment of BPHCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Dry Eye TreatmentCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Alzheimers Disease TreatmentCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Point of Care Oncology DiagnosticsCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site
→ Alveus TherapeuticsCompanyPortfolio listing
Sep 14, 2026 to presentfactThe subject's own site

Employs (14)

→ Lauren ExpositoPersonInvestor Relations Associate
factThe subject's own site
→ Megan McDermottPersonExecutive Assistant
factThe subject's own site
→ Clarisa GonsalvesPersonExecutive Administrative Assistant
factThe subject's own site
→ Transformative GrowthPersonPortfolio
factThe subject's own site
→ Nayan Gregory ParekhPersonFounder & Managing Partner
factThe subject's own site
→ Subhanu SaxenaPersonManaging Partner & Chief Compliance Officer
Apr 1, 2018 to presentfactForm ADV, The subject's own site
→ Bill EngelsPersonChief Finance Officer
factThe subject's own site
→ Chris FerrisPersonHead of Investor Relations
factThe subject's own site
→ Akhil AkulaPersonPrincipal
factThe subject's own site
→ Jonathan SollPersonVice President
factThe subject's own site
→ Russell KeathleyPersonVice President
factThe subject's own site
→ Nayan Greg ParekhPersonFounder & Managing Partner
Apr 1, 2018 to presentfactForm ADV
→ Ivan Philip GergelPersonManaging Partner & Chief Medical Officer
Apr 1, 2018 to presentfactForm ADV
→ Robert William CzesakPersonChief Financial Officer
Dec 1, 2023 to presentfactForm ADV

Manages (5)

→ NEW Rhein Healthcare 2021 (lux) ScspFundVenture Capital Fund
Mar 28, 2022 to presentfactForm ADV
→ NEW Rhein Healthcare 2021 (de) LPFundVenture Capital Fund
Mar 28, 2022 to presentfactForm ADV
→ NEW Rhein Healthcare 2021 PrivakFundVenture Capital Fund
Mar 28, 2024 to presentfactForm ADV
→ NEW Rhein Healthcare 18 (parallel) ScspFundPrivate Equity Fund
Mar 30, 2020 to presentfactForm ADV
→ NEW Rhein Healthcare 18 LPFundPrivate Equity Fund
Feb 15, 2019 to presentfactForm ADV

Dated events

5 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Dec 1, 2023
Person joined
Robert William Czesak joined Schedule A of NEW Rhein Healthcare Investors LLC as Chief Financial Officer
Form ADVobserved 9 days ago
Occurred
Feb 15, 2019
Adviser's first ADV filing
NEW Rhein Healthcare Investors LLC first filed Form ADV (ERA)
Form ADVobserved 9 days ago
Occurred
Apr 1, 2018
Person joined
Ivan Philip Gergel joined Schedule A of NEW Rhein Healthcare Investors LLC as Managing Partner & Chief Medical Officer
Form ADVobserved 9 days ago
Occurred
Apr 1, 2018
Person joined
Subhanu Saxena joined Schedule A of NEW Rhein Healthcare Investors LLC as Managing Partner
Form ADVobserved 9 days ago

Show 5 bookkeeping events

Occurred
Mar 28, 2024
NEW Rhein Healthcare 2021 Privak first reported on Form ADV by NEW Rhein Healthcare Investors LLC (Venture Capital Fund), GAV $20,263,442
Occurred
Mar 28, 2022
NEW Rhein Healthcare 2021 (lux) Scsp first reported on Form ADV by NEW Rhein Healthcare Investors LLC (Venture Capital Fund)
Occurred
Mar 28, 2022
NEW Rhein Healthcare 2021 (de) LP first reported on Form ADV by NEW Rhein Healthcare Investors LLC (Venture Capital Fund)
Occurred
Mar 30, 2020
NEW Rhein Healthcare 18 (parallel) Scsp first reported on Form ADV by NEW Rhein Healthcare Investors LLC (Private Equity Fund), GAV $26,350,000
Occurred
Feb 15, 2019
NEW Rhein Healthcare 18 LP first reported on Form ADV by NEW Rhein Healthcare Investors LLC (Private Equity Fund), GAV $21,845,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV) · as of 2026-09-12

Also named here, with no published line of their own (reach them through the firm): Lauren Exposito (Investor Relations Associate), Megan McDermott (Executive Assistant), Clarisa Gonsalves (Executive Administrative Assistant), Transformative Growth (Portfolio), Nayan Gregory Parekh (Founder & Managing Partner), Subhanu Saxena (Managing Partner & Chief Compliance Officer), Bill Engels (Chief Finance Officer), Chris Ferris (Head of Investor Relations), Akhil Akula (Principal), Jonathan Soll (Vice President), Russell Keathley (Vice President), Nayan Greg Parekh (Founder & Managing Partner).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:8c930703-26ab-4176-ba2f-559fed009018
First observed: Sep 12, 2026
Last observed: Sep 12, 2026 9 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

NEW Rhein Healthcare Investors LLC

Venture Capital

Philadelphia, PA

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:8c930703-26ab-4176-ba2f-559fed009018

Data as of Sep 12, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 10:09 PM UTC and rebuilt at most every 15 minutes.